JHepatol[Jour]AND74[volume]AND1[issue]

肝病学杂志74卷1期

1

COVID-19:Discovery,diagnosticsanddrugdevelopment.

COVID-19：发现、诊断和药物开发。

AsselahT,DurantelD,PasmantE,LauG,SchinaziRF.

JHepatol.Jan;74(1):-.

2

Hepatocytepyroptosisandreleaseofinflammasomeparticlesinducestellatecellactivationandliverfibrosis.

肝细胞热下垂和炎性颗粒释放诱导星状细胞活化和肝纤维化。

GaulS,LeszczynskaA,AlegreF,KaufmannB,JohnsonCD,AdamsLA,WreeA,DammG,SeehoferD,CalventeCJ,PoveroD,KisselevaT,EguchiA,McGeoughMD,HoffmanHM,PelegrinP,LaufsU,FeldsteinAE.

JHepatol.Jan;74(1):-.

3

ImpactofCOVID-19onglobalHCVeliminationefforts.

COVID-19对全球消除HCV努力的影响。

BlachS,KondiliLA,AghemoA,CaiZ,DuganE,EstesC,GamkrelidzeI,MaS,PawlotskyJM,Razavi-ShearerD,RazaviH,WakedI,ZeuzemS,CraxiA.

JHepatol.Jan;74(1):31-36.

4

MicroRNA--3pisapotenttumoursuppressorinhepatocellularcarcinoma.

MicroRNA--3p在肝细胞癌中是一种有效的肿瘤抑制因子。

KomollRM,HuQ,OlarewajuO,vonD?hlenL,YuanQ,XieY,TsayHC,DaonJ,QinR,MannsMP,SharmaAD,GogaA,OttM,BalakrishnanA.

JHepatol.Jan;74(1):-.

5

Epidemiologicalpattern,incidence,andout

欢迎转载,转载请注明原文网址：http://www.xkimr.com/zzyfl/101171.html